[ad_1]
New York, July 26, 2021 /PRNewswire/ – The market for intensive care diagnostics in the healthcare supplies industry is expected to grow $1.83 billion The period 2021-2025. Technavio’s latest market research report estimates that the critical care diagnostic market will grow at a compound annual growth rate of 17.40%. The report provides the latest analysis on current market conditions, the latest trends and driving factors, and the overall market environment.
Technavio provides the latest analysis on the current global market situation and the overall market environment.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Major markets of Abbott Laboratories, Becton, Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Quidel Corp., and Siemens AG Participant.
Increasing attention to the diagnosis of chronic and infectious diseases will provide tremendous growth opportunities. In order to take advantage of current opportunities, market suppliers must gain a foothold in the fast-growing market segment while maintaining their position in the slow-growing market segment.
2021-2025 Critical Care Diagnostics Market: Segmentation
The intensive care diagnostic market segmentation is as follows:
- application
- Microbiological and infectious disease testing
- Hematology testing
- Heart and lipid testing
- Coagulation test
- other
- geography
- North America
- Europe
- Asia
- Row
To learn more about the global trends affecting the future of market research, download the free sample:
https://www.technavio.com/talk-to-us?report=IRTNTR43701
Critical Care Diagnostics Market 2021-2025: Vendor Analysis and Scope
some…
The full story on Benzinga.com
[ad_2]
Source link
